Detailed Mechanism Funding and Narrative

Years of mechanism: 2014 2015 2016 2017 2018 2019

Details for Mechanism ID: 17531
Country/Region: Namibia
Year: 2016
Main Partner: IntraHealth International, Inc.
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: USAID
Total Funding: $2,000,000 Additional Pipeline Funding: $1,800,000

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $0
Care: TB/HIV (HVTB) $0
Care: Pediatric Care and Support (PDCS) $0
Strategic Information (HVSI) $0
Health Systems Strengthening (OHSS) $0
Testing: HIV Testing and Counseling (HVCT) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $0
Treatment: Adult Treatment (HTXS) $2,000,000
Treatment: Pediatric Treatment (PDTX) $0
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 931
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 1,697
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 686
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 393
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 10,548
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 15,788
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 4,287
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 1,963
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 17,768
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 21,138
HTS_TST Service Delivery Point (Facility): Inpatient 2017 1,563
HTS_TST Service Delivery Point (Facility): Inpatient 2017 1,539
HTS_TST Service Delivery Point (Facility): Outpatient 2017 9,960
HTS_TST Service Delivery Point (Facility): Outpatient 2017 7,825
HTS_TST Service Delivery Point (Facility): PMTCT 2017 1,470
HTS_TST Service Delivery Point (Facility): PMTCT 2017 8,920
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 381
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 239
HTS_TST Service Delivery Point (Facility): VCT 2017 247
HTS_TST Sum of Aggregated Age/Sex <15 2017 1,617
HTS_TST Sum of Aggregated Age/Sex <15 2017 2,090
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 14,835
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 17,751
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 16,452
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 19,841
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 53
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 90
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 40
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 37
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 762
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 951
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 479
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 221
PMTCT_ART Already on ART at beginning of current pregnancy 2017 1,234
PMTCT_ART New on ART 2017 439
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 9,530
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 51
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 308
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 211
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 976
PMTCT_EID Number of infants with a positive virological test result within 12 months of birth 2017 3
PMTCT_EID Number of infants with a positive virological test result within 12 months of birth 2017 7
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 2
PMTCT_EID Sum of Infant Age disaggregates 2017 262
PMTCT_EID Sum of Infant Age disaggregates 2017 1,284
PMTCT_STAT By: Known positives at entry 2017 314
PMTCT_STAT By: Known positives at entry 2017 1,563
PMTCT_STAT By: Number of new positives identified 2017 90
PMTCT_STAT By: Number of new positives identified 2017 405
PMTCT_STAT Number of new ANC and L&D clients 2017 1,722
PMTCT_STAT Number of new ANC and L&D clients 2017 10,055
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 1,646
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 9,530
PMTCT_STAT Sum of Positives Status disaggregates 2017 404
PMTCT_STAT Sum of Positives Status disaggregates 2017 1,968
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 1
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 7
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 44
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 264
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 2
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 11
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 53
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 332
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 104
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 640
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 100
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 614
TB_SCREENDX [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 726
TB_SCREENDX [Sub-Disagg of Screen Results] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 34
TB_SCREENDX [Sub-disagg of Specimen Sent] Diagnostic Test: Other (Not Xpert) 2017 32
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: other (not Xpert) 2017 442
TB_SCREENDX [Sub-disagg of Specimen Sent] Diagnostic Test: Smear Only 2017 1
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Smear only 2017 34
TB_SCREENDX [Sub-disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 1
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 19
TB_SCREENDX Screen Result: Screened Positive for TB 2017 726
TB_SCREENDX Screen Results: Screened Positive for TB 2017 34
TB_SCREENDX Screened for TB by Age/Sex: <15 Female 2017 42
TB_SCREENDX Screened for TB by Age/Sex: <15 Male 2017 42
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 383
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 8,754
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 382
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 8,752
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 973
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 973
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 849
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 19,453
TX_CURR Aggregated Age/Sex: <15 Female 2017 42
TX_CURR Aggregated Age/Sex: <15 Female 2017 1,086
TX_CURR Aggregated Age/Sex: <15 Male 2017 42
TX_CURR Aggregated Age/Sex: <15 Male 2017 1,086
TX_CURR Aggregated Age/Sex: 15+ Female 2017 643
TX_CURR Aggregated Age/Sex: 15+ Female 2017 16,319
TX_CURR Aggregated Age/Sex: 15+ Male 2017 486
TX_CURR Aggregated Age/Sex: 15+ Male 2017 12,444
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 1,213
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 30,934
TX_CURR Sum of Aggregated Age/Sex <15 2017 84
TX_CURR Sum of Aggregated Age/Sex <15 2017 2,172
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 1,129
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 28,763
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 1,213
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 30,935
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 9
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 153
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 9
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 151
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 139
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 2,259
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 105
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 1,731
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 262
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 4,292
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 262
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 4,294
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 35
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 21,775
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 1
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 717
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 1
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 717
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 19
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 10,901
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 14
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 8,263
TX_PVLS Numerator: Indication: Routine 2017 20
TX_PVLS Numerator: Indication: Routine 2017 18,922
TX_PVLS Numerator: Indication: Targeted 2017 15
TX_PVLS Numerator: Indication: Targeted 2017 2,737
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 138
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 138
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 14
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,927
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 10
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,485
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 26
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 3,698
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 30
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 4,203
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 149
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 148
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 16
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 2,186
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 12
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,722
Cross Cutting Budget Categories and Known Amounts Total: $325,769
Human Resources for Health $325,769